Qutenza® (capsaicin) – Expanded indication
July 17, 2020 - The FDA approved Averitas Pharma’s Qutenza (capsaicin), in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet.
Download PDF
